Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

1737 ARTÍCULOS , VIENDO DEL 1366 AL 1380

Genetics of Parkinson disease and other movement disorders

Kumar KR, Lohmann K, Klein C.

Curr Opin Neurol. 2012 Aug;25(4):466-74. doi: 10.1097/WCO.0b013e3283547627.

The treatment of restless legs syndrome and periodic limb movement disorder in adults--an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline

Aurora RN, Kristo DA, Bista SR, Rowley JA, Zak RS, Casey KR, Lamm CI, Tracy SL, Rosenberg RS; American Academy of Sleep Medicine.

Sleep. 2012 Aug 1;35(8):1039-62. doi: 10.5665/sleep.1988.

Characterization of periodic upper limb movement disorder in a patient with restless arms syndrome

Ruppert E, Cretin B, Meyer C, Kilic-Huck U, Bourgin P.

Mov Disord. 2012 Sep 15;27(11):1459-61. doi: 10.1002/mds.25154. Epub 2012 Aug 23.

Rhythmic movement disorder associated with restless legs syndrome

Vitello N, Bayard S, Lopez R, Carlander B, Dauvilliers Y, Cochen De Cock V.

Sleep Med. 2012 Dec;13(10):1324-5. doi: 10.1016/j.sleep.2012.08.011. Epub 2012 Oct 10.

Night-to-night variability of periodic leg movements during sleep in restless legs syndrome and periodic limb movement disorder: comparison between the periodicity index and the PLMS index

Ferri R, Fulda S, Manconi M, Högl B, Ehrmann L, Ferini-Strambi L, Zucconi M.

Sleep Med. 2013 Mar;14(3):293-6. doi: 10.1016/j.sleep.2012.08.014. Epub 2012 Oct 12.

Non-respiratory indications for polysomnography and related procedures in children: an evidence-based review

Kotagal S, Nichols CD, Grigg-Damberger MM, Marcus CL, Witmans MB, Kirk VG, D'Andrea LA, Hoban TF.

Sleep. 2012 Nov 1;35(11):1451-66. doi: 10.5665/sleep.2188.

Practice parameters for the non-respiratory indications for polysomnography and multiple sleep latency testing for children

Aurora RN, Lamm CI, Zak RS, Kristo DA, Bista SR, Rowley JA, Casey KR.

Sleep. 2012 Nov 1;35(11):1467-73. doi: 10.5665/sleep.2190.

Update on sleep and its disorders

Pack AI, Pien GW.

Annu Rev Med. 2011;62:447-60. doi: 10.1146/annurev-med-050409-104056.

Sleep disorders, medical conditions, and road accident risk

Smolensky MH, Di Milia L, Ohayon MM, Philip P.

Accid Anal Prev. 2011 Mar;43(2):533-48. doi: 10.1016/j.aap.2009.12.004.

[Restless legs syndrome and cardiovascular risk]

Schulte EC, Spieler D, Winkelmann J.

Nervenarzt. 2011 Aug;82(8):1006-11. doi: 10.1007/s00115-010-3185-3.

A 52-week study of gabapentin enacarbil in restless legs syndrome

Ellenbogen AL, Thein SG, Winslow DH, Becker PM, Tolson JM, Lassauzet ML, Chen D.

Clin Neuropharmacol. 2011 Jan-Feb;34(1):8-16. doi: 10.1097/WNF.0b013e3182087d48.

A phase I, single-dose study of the disposition of 14C-radiolabeled gabapentin enacarbil in healthy male volunteers

Lal R, Sukbuntherng J, Ho J, Cundy KC.

Int J Clin Pharmacol Ther. 2011 Feb;49(2):109-15. doi: 10.5414/cpp49109.

Evaluation of painful sensory symptoms in restless legs syndrome: experience from two clinical trials

Hornyak M, Sohr M, Busse M; 604 and 615 Study Groups.

Sleep Med. 2011 Feb;12(2):186-9. doi: 10.1016/j.sleep.2010.11.007. Epub 2011 Jan 21.

Genome-wide association studies of sleep disorders

Raizen DM, Wu MN.

Chest. 2011 Feb;139(2):446-452. doi: 10.1378/chest.10-1313.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias